Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 5, 2006, Pages 317-326

  Varas Lorenzo, Cristina ^a,b   Rueda de Castro, Ana Maria ^a   Maguire, Andrew ^a,b   Miret, Montserrat ^a,c  

^a Novartis Farmaceutica SA   (Spain)

^b PFIZER INC   (United States)

^c Seono International SA   (Switzerland)

Author keywords

Cardiovascular risk factors; Diabetes; Elderly; Glucose metabolism impairment

Indexed keywords

GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HISPANIC; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

EID: 33744459468     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1229     Document Type: Article

References (31)

1. King H, Aubert RE, Herman WH, Suboticanec KB. Global burden of diabetes: estimates for 1997. CVD Prevention 1998; 1: 243-258.
2. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. Diabetes Care 1998; 21(4): 518-524.
3. Geiss LS, Herman WH, Smith PJ. Mortality in Non-Insulin-Dependent Diabetes. In Diabetes in America. National Diabetes Data Group (ed.). National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468: Bethesda, MD, 1995; 233-258.
4. Complications of Diabetes. In Diabetes in America. National Diabetes Data Group (ed.). National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468: Bethesda, MD, 1995; 259-507.
5. Jarrett RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabetes Med 1996; 13: S15-S19.
6. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998; 21: 1236-1239.
7. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 1999; 144: 229-235.
8. The DECODE study group, European Diabetes Epidemiology Group. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
9. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports: manual for Medical Technicians and Laboratory Procedures Used for NHANES III (CD-ROM), 1996.
10. Expert Committee. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
11. Alberti KGMM, Zimmet PZfor the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998; 15: 539-553.
12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods (2nd edn). World Health Organization: Geneva, 1982.
13. Standards of medical care far patients with diabetes mellitus. American Diabetes Association. Diabetes Care 1998; 21 (Suppl. 1): 523-531.
14. Myers GL, Cooper GR, Winn CL, Smith SJ. The centers for disease control-national heart, long and blood institute lipid standardization program: An approach to accurate and precise lipid measurements. Clin Lab Med 1989; 9: 105-135.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Mohadjer L, Montaquila J, Waksberg J. NHANES III: Weighting and Estimation Methodology: NCHS Executive Summary. National Center for Health Statistics: Hyattsville, MD, 1996.
17. Ezzati T, Wakesberg J, Chu A, Maurer K. Sample design: Third National Health and Nutrition Examination Survey 1988-1994. Hyattville, Md: National center for health Statistics; 1992. Vital and Health Statistics, series 2, NO 113.
18. Shah BV, Barnwell BG, Bieler S. SUDAAN User's Manual, Release 7.5. Research Triangle Institute: Research Triangle Park, NC, 1997.
19. SAS Institute Inc., SAS/STAT User's Guide, Version 8, Cary, NC. 1999.
20. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
21. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999; 22: 403-408.
22. Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M. Glycemic control of older adults with type 2 diabetes: Findings from the Third National Health and Nutrition Survey, 1988-1994. J Am Geriatr Soc 2000; 48: 264-267.
23. Erlinger TP, Brancati FL. Postchallenge hyperglycemia in a national sample of US adults with type 2 diabetes. Diabetes Care 2001; 24: 1734-1738.
24. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Hem 1992; 38: 1933-1953.
25. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes. Prevalence, incidence, and risk factors. Diabetes Care 2001; 24(9): 1614-1619.
26. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-2673.
27. Resnick HE, Harris MI, Brock DB, Harris TB. American diabetes association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles. Results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23: 176-180.
28. Alexander ChM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors and prevalence of coronary heart disease. Am J Cardiol 2000; 86: 897-902.
29. Barzilay JI, Spiekerman ChF, Kuller LH, et al. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders. The cardiovascular health study. Diabetes Care 2001; 24: 1233-1239.
30. Barzilay JI, Spiekerman ChF, Wahl PW, et al. Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 1999; 354: 622-625.
31. Jacobson TA, Griffiths GG, Varas C, Gause D, Sung JCY, Ballantyne ChM. Impact of evidence-based clinical judgment on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. Arch Intern Med 2000; 160: 1361-1369.